Janssen to Title Sponsor NASCAR Sprint Cup Race at Chicagoland Speedway

July 30, 2014

Chicagoland Speedway today announced Janssen Pharmaceuticals, Inc., the official cardiovascular partner of NASCAR, as the title sponsor of this year’s first Chase for the NASCAR Sprint Cup race.

The MyAFibStory.com 400 will take place on Sunday, September 14, 2014 in recognition of National AFib Awareness Month, running throughout September.

Atrial Fibrillation, or AFib, is a condition caused by an irregular heartbeat that impacts as many as 2.7 million Americans. 

“The first race in the Chase for the NASCAR Sprint Cup provides a unique and elevated stage within the sport, one that delivers an excellent opportunity to raise awareness of atrial fibrillation with the MyAFibStory.com 400,” said Scott Paddock, President of Chicagoland Speedway. “We are proud to be partnering with Janssen, and we have a number of events and activation opportunities planned to educate and encourage race fans on AFib, risks and warning signs and treatment for the condition.”

Janssen became involved with NASCAR in an official capacity earlier this year, sponsoring both a NASCAR Nationwide Series™ Race at Auto Club Speedway and Brian Vickers’ No. 55 Toyota, NASCAR Sprint Cup Series™ Sprint Cup ride at the Southern Californiafacility.

“Millions of Americans are living with AFib, and could have an increased risk for an AFib-related stroke if it is not being treated properly,” said Gregg Ruppersberger, Group Product Director, Janssen. “That’s why we and Chicagoland Speedway are partnering to educate people about the risk factors and warning signs for AFib, stroke, blood clot prevention and treatment options. Together, we can make a difference for people who are at risk for or living with AFib.”